| Katherine Wilson, | |
|
2846 Brandt Dr S, Fargo, ND 58104-8805 | |
| (701) 232-2340 | |
| (701) 232-2330 |
| Full Name | Katherine Wilson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2846 Brandt Dr S, Fargo, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003110099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1151 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Wilson, 2846 Brandt Dr S, Fargo, ND 58104-8805 Ph: (701) 232-2340 | Katherine Wilson, 2846 Brandt Dr S, Fargo, ND 58104-8805 Ph: (701) 232-2340 |
News Archive
In the Center for Global Development's "Global Health Policy"(CGD) blog, Victoria Fan, a CGD research fellow, and Rachel Silverman, a research assistant for the CGD global health team, examine the potential reasons behind "the U.S. government's apparent lack of support, particularly its legislated 'opt-in' stance," on the Affordable Medicines Facility for Malaria (AMFm), and they note "AMFm's continued survival is all but impossible without an explicit endorsement by the U.S. Global Malaria Coordinator who leads the U.S. President's Malaria Initiative."
ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)].
Once damaged, the human heart does a poor job of repairing itself, so this is a key priority for treating heart failure. One way of restoring cardiac function is to reprogram non-cardiac body cells such as fibroblasts into heart muscle cells (cardiomyocytes) using a collection of cardiac transcription factors.
› Verified 9 days ago
Mrs. Jill S Erickson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1727 South 16th Street, Fargo, ND 58103 Phone: 701-446-4800 | |
Sarah Hoepfner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6970 Fax: 701-234-7391 | |
Nancy Knowlton, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 11th Ave S, Beyond Boundaries Speech-language, Fargo, ND 58103 Phone: 701-356-0062 Fax: 701-356-5412 | |
Kayla Marie Flach, MSLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 4500 36th Ave S Ste 200, Fargo, ND 58104 Phone: 701-532-1507 Fax: 701-532-1529 | |
Sydney M Honek, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4152 30th Ave S, Fargo, ND 58104 Phone: 701-551-1750 | |
Kids First Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1102 7th St S, Fargo, ND 58103 Phone: 701-866-9529 |